PCSK9 inhibitors – new era of dyslipidemia treatment - effectiveness in reducing low-density lipoprotein (LDL-C) and cardiovascular risk

PCSK9 inhibitors – new era of dyslipidemia treatment - effectiveness in reducing low-density lipoprotein (LDL-C) and cardiovascular risk

Introduction: Abnormal blood cholesterol levels in patients with increased cardiovascular risk have a worse prognosis for patient survival. Treating dyslipidemia is important because it can improve patient comfort and safety. It sometimes happens that currently used drugs to lower cholesterol are n...

Full description

Saved in:
Bibliographic Details
Main Authors: Radosław Szydłowski, Magdalena Bodera, Hanna Porwolik, Agata Porwolik, Patrycja Pabis, Agnieszka Porwolik, Dominik Rabstein, Piotr Gościniewicz
Format: Article
Language:English
Published: Nicolaus Copernicus University in Toruń 2024-12-01
Series:Quality in Sport
Subjects:
PCSK9 inhibitors
cardiovascular disease
dyslipidemia
Online Access:https://apcz.umk.pl/QS/article/view/56299
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items